Beneficial Effect of Bee Venom Therapy as an Adjunctive Treatment of Parkinson's Disease: A Systematic Review & Meta-Analysis
-
Nicolas Daniel Widjanarko
,
Felicia Grizelda Suryatenggara
,
Putu Clara Shinta Gelgel
,
Joseph Izmardha Couteau
,
Nisrina Salsabila Firmansyah
,
Laila Fitria Djaimi
,
Nabila Cindi Ediwi
Abstract
The second most prevalent progressive neurodegenerative disorder in the world is Parkinson's disease (PD). According to many studies, the majority of the existing PD therapies are symptomatic and may result in motor problems, such as dyskinesia and fluctuations. To overcome these complications, various reports have proposed the use of bee venom as an effective treatment. Bee venom can suppress the neuroinflammation effect in PD mouse models, indicating its potential as an effective adjuvant treatment for the disease in humans. Thus, the purpose of this study was to evaluate the therapeutic potential of bee venom treatment (BVT) as a PD adjuvant. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 standards were followed during the processes. In addition, a literature search was performed on various electronic databases, including PubMed, EBSCO, and ProQuest. After evaluating the included papers' quality using the Risk of Bias Tool 2.0 (RoB 2) as well as RoB In Non-randomized Studies of Interventions (ROBINS-I), a meta-analysis was carried out using Review Manager (RevMan) 5.4. Four publications in total have been analyzed in the systematic review as well as meta-analysis based on the inclusion criteria. The results showed that three and one articles had low and moderate risk of bias, respectively. The BDI score between the bee venom and control groups had a statistically significant p-value (SMD=-0.52, 95%CI= -0.93 to -0.11, p=0.01) according to the meta-analysis. Nevertheless, following the therapy, there were no discernible improvements in UPDRS II, III, and II+III, as well as PDQL, gait speed & number, MXE, and DCL. The findings also showed that bee venom significantly improved BDI scores in PD patients. Although the positive trends observed in other outcomes were not statistically significant, further investigation with larger cohorts is required to validate these findings.
Cho SY, Lee YE, Doo KH, Lee JH, Jung WS, et al. Efficacy of combined treatment with acupuncture and bee venom acupuncture as an adjunctive treatment for Parkinson’s disease. J Altern Complement Med N Y N 2018;24:25-32.
Jankovic J, Tan EK. Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 2020;91:795-808.
Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet Lond Engl 2021;12:2284-2303.
Zahoor I, Shafi A, Haq E. Pharmacological Treatment of Parkinson’s Disease. In: Stoker TB, Greenland JC, editors. Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications; 2018 [cited 2022 Apr 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK536726/
Awad K, Abushouk AI, AbdelKarim AH, Mohammed M, Negida A, et al. Bee venom for the treatment of Parkinson’s disease: How far is it possible? Biomed Pharmacother Biomedecine Pharmacother 2017;91:295-302.
Jang S, Kim KH. Clinical effectiveness and adverse events of bee venom therapy: a systematic review of randomized controlled trials. Toxins 2020;12:558.
Wehbe R, Frangieh J, Rima M, El Obeid D, Sabatier JM, et al. Bee venom: overview of main compounds and bioactivities for therapeutic interests. Molecules 2019;24:2997.
Bellik Y. Bee venom: its potential use in alternative medicine. Anti-Infect Agents 2015;13:3-16.
Lin TY, Hsieh CL. Clinical applications of bee venom acupoint injection. Toxins 2020;12:618.
Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, et al. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 2007;7:1092-1101.
Alvarez-Fischer D, Noelker C, Vulinović F, Grünewald A, Chevarin C, et al. Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model. PloS One 2013;8:e61700.
Kin K, Yasuhara T, Kameda M, Date I. Animal Models for Parkinson’s disease research: trends in the 2000s. Int J Mol Sci 2019;20:5402.
Doo AR, Kim ST, Kim SN, Moon W, Yin CS, et al. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson’s disease. Neurol Res 2010;32:88-91.
Khalil WKB, Assaf N, ElShebiney SA, Salem NA. Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis. Neurochem Int 2015;80:79-86.
Klarendić M, Kirbiš M, Mojsovska E, Kavčič M, Sadikov A, et al. Bee venom does not reduce the risk for parkinson’s disease: epidemiological study among beekeepers. Mov Disord Off J Mov Disord Soc 2022;37:211-213.
Cho SY, Shim SR, Rhee HY, Park HJ, Jung WS, et al. Effectiveness of acupuncture and bee venom acupuncture in idiopathic Parkinson’s disease. Parkinsonism Relat Disord 2012;18:948-952.
Hartmann A, Müllner J, Meier N, Hesekamp H, van Meerbeeck P, et al. Bee venom for the treatment of parkinson disease - a randomized controlled clinical trial. PloS One 2016;11:e0158235.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 2021;10:89.
Doo KH, Lee JH, Cho SY, Jung WS, Moon SK, et al. A prospective open-label study of combined treatment for idiopathic Parkinson’s disease using acupuncture and bee venom acupuncture as an adjunctive treatment. J Altern Complement Med N Y N 2015;21:598-603.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018;27:1785-1805.
Bezerra CT, Grande AJ, Galvão VK, dos Santos DHM, Atallah ÁN, et al. Assessment of the strength of recommendation and quality of evidence: GRADE checklist. A descriptive study. São Paulo Med J 2022;140:829-836.
Iosr Journals, Safaa Diab Abd El- Wahab, Eita LH. The Effectiveness of Live Bee Sting Acupuncture on Depression. In Figshare; 2015 [cited 2024 Jan 30]. Available from: https://figshare.com/articles/The_Effectiveness_of_Live_Bee_Sting_Acupuncture_on_Depression/1485544/1
Bordon K de CF, Cologna CT, Fornari-Baldo EC, Pinheiro-Júnior EL, Cerni FA, et al. From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery. Front Pharmacol 2020;11.
Khalil A, Elesawy BH, Ali TM, Ahmed OM. Bee venom: from venom to drug. Molecules 2021;26:4941.
| Issue | Vol 10, No 1, 2025 -In Press- | |
| Section | Review Article(s) | |
| Keywords | ||
| Acupuncture therapy Apitherapy Bee venom therapy Parkinson’s disease | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
